Home | Biogen
Biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. Biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while ...
Careers | Biogen
Everyone at Biogen contributes to our mission to create transformative medicines for people who need them the most. Explore our business areas to discover where you can make an impact on our team.
Company | Biogen
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
Pipeline - Biogen
Biogen. Science & Innovation. Pipeline. Breaking New Ground With Science. With a strong focus on difficult-to-treat diseases, our pipeline is focused on research in therapeutic areas where we believe we have the best opportunity to deliver transformational medicines to patients and protect public health. This is made possible by people who ...
Investor Relations | Biogen
Jan 13, 2025 · Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities.
Charting a Bold New Path in Lupus Innovation and Trial ... - Biogen
Jan 21, 2025 · Decades of study and industry-shaping innovation in neuroimmunology and immunology have given Biogen deep insight to understand multiple modalities targeting immune cell pathways anticipated to modulate the disease.
Medicines - Biogen
Nov 1, 2024 · For product information for other countries, please visit your country's Biogen affiliate website. Last Updated: November 1, 2024 *Important ADUHELM Update: ADUHELM® (aducanumab-avwa) is no longer available. For product information, please visit FDA.gov. To view labeling and access review documents, please visit drugs@FDA.
Multiple Sclerosis - Biogen
As pioneers in neuroscience, Biogen has an innovative therapeutic pipeline that aims to reverse disability, repair damage, and address other remaining unmet needs in MS, with the goal of significantly altering the course of MS and preventing disease development and …
Kidney Disease | Biogen
Through our acquisition of Human Immunology Biosciences (HI-Bio) in July 2024, Biogen officially entered the nephrology space with a portfolio of investigational drugs that target immune-mediated diseases with serious unmet need.
Environment - Biogen
Acting on our understanding of the complex links between health and the environment, our sustainability strategy focuses on three core pillars: responsible product development, sustainable operations and engaged suppliers. Together with passionate Biogen employees and other stakeholders, we aim to advance a healthier and more sustainable world.